These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 28691227)

  • 1. Changes in the plasma membrane in metabolic disease: impact of the membrane environment on G protein-coupled receptor structure and function.
    Desai AJ; Miller LJ
    Br J Pharmacol; 2018 Nov; 175(21):4009-4025. PubMed ID: 28691227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The current state of GPCR-based drug discovery to treat metabolic disease.
    Sloop KW; Emmerson PJ; Statnick MA; Willard FS
    Br J Pharmacol; 2018 Nov; 175(21):4060-4071. PubMed ID: 29394497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular pharmacology of GPCRs.
    Langmead CJ; Summers RJ
    Br J Pharmacol; 2018 Nov; 175(21):4005-4008. PubMed ID: 30302756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GPCR signalling from within the cell.
    Jong YI; Harmon SK; O'Malley KL
    Br J Pharmacol; 2018 Nov; 175(21):4026-4035. PubMed ID: 28872669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GPCRs in context: sexual dimorphism in the cardiovascular system.
    Mouat MA; Coleman JLJ; Smith NJ
    Br J Pharmacol; 2018 Nov; 175(21):4047-4059. PubMed ID: 29451687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The roles of RGS proteins in cardiometabolic disease.
    McNeill SM; Zhao P
    Br J Pharmacol; 2024 Jul; 181(14):2319-2337. PubMed ID: 36964984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular pharmacology of G protein-coupled receptors.
    Summers RJ
    Br J Pharmacol; 2016 Oct; 173(20):2931-3. PubMed ID: 27682321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highlights and hot topics in GPCR research from 'Down Under'.
    Smith NJ; May LT; Grimsey NL
    Br J Pharmacol; 2024 Jul; 181(14):2091-2094. PubMed ID: 38798136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying ligands at orphan GPCRs: current status using structure-based approaches.
    Ngo T; Kufareva I; Coleman JLj; Graham RM; Abagyan R; Smith NJ
    Br J Pharmacol; 2016 Oct; 173(20):2934-51. PubMed ID: 26837045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superagonism at G protein-coupled receptors and beyond.
    Schrage R; De Min A; Hochheiser K; Kostenis E; Mohr K
    Br J Pharmacol; 2016 Oct; 173(20):3018-27. PubMed ID: 26276510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic potential of allosteric modulators for the treatment of gastrointestinal motility disorders.
    Saito A; Alvi S; Valant C; Christopoulos A; Carbone SE; Poole DP
    Br J Pharmacol; 2024 Jul; 181(14):2232-2246. PubMed ID: 36565295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic validation of an orphan G protein-coupled receptor: The case of GPR84.
    Marsango S; Barki N; Jenkins L; Tobin AB; Milligan G
    Br J Pharmacol; 2022 Jul; 179(14):3529-3541. PubMed ID: 32869860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The application of targeted protein degradation technologies to G protein-coupled receptors.
    Keen AC; Jörg M; Halls ML
    Br J Pharmacol; 2024 Jul; 181(14):2351-2358. PubMed ID: 36965004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single nucleotide variations encoding missense mutations in G protein-coupled receptors may contribute to autism.
    van der Westhuizen ET
    Br J Pharmacol; 2024 Jul; 181(14):2158-2181. PubMed ID: 36787962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signalling in response to sub-picomolar concentrations of active compounds: Pushing the boundaries of GPCR sensitivity.
    Civciristov S; Halls ML
    Br J Pharmacol; 2019 Jul; 176(14):2382-2401. PubMed ID: 30801691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenomedullin 2/intermedin: a putative drug candidate for treatment of cardiometabolic diseases.
    Zhang SY; Xu MJ; Wang X
    Br J Pharmacol; 2018 Apr; 175(8):1230-1240. PubMed ID: 28407200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular insights into orphan G protein-coupled receptors relevant to schizophrenia.
    Lu Y; Hatzipantelis CJ; Langmead CJ; Stewart GD
    Br J Pharmacol; 2024 Jul; 181(14):2095-2113. PubMed ID: 37605621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional crosstalk between angiotensin receptors (types 1 and 2) and relaxin family peptide receptor 1 (RXFP1): Implications for the therapeutic targeting of fibrosis.
    Samuel CS; Li Y; Wang Y; Widdop RE
    Br J Pharmacol; 2024 Jul; 181(14):2302-2318. PubMed ID: 36560925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution, physiology and pharmacology of relaxin-3/RXFP3 systems in brain.
    Ma S; Smith CM; Blasiak A; Gundlach AL
    Br J Pharmacol; 2017 May; 174(10):1034-1048. PubMed ID: 27774604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the pro-inflammatory G protein-coupled receptor GPR84.
    Marsango S; Milligan G
    Br J Pharmacol; 2024 May; 181(10):1500-1508. PubMed ID: 37085331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.